Drugstore sign in Italy Photo: Courtesy of Milano Finanza

In the Italian healthcare landscape, with  a specific focus on the pharmacy channel and the pharmaceutical sector, Value4Pharma has developed a new Integrated Trading model that structurally redefines traditional goods exchange. This is not just a simple terminological update, but an industrial evolution that transforms barter from a tactical lever into a strategic tool for financial, commercial, and media planning. 

At the core is the precise vision of the Sole Administrator of the company, Alessandro Tabasso, who has identified a historical limitation of the market. "Traditional barter has often been considered an inadequate tool," explains Tabasso. "We chose to rethink it in industrial terms, introducing transparency, control, and strategic integration. Our goal is not to replace cash, but to integrate it coherently. It is from this cultural evolution, even before it becomes operational, that Integrated Trading takes shape."

The legal principle is that of synallagma: The service is remunerated in goods rather than money, however, the real innovation does not lie in the form of exchange, but in its management. Through Value4Pharma, the industry retains full control over the destination of products, and value is created in the ability to transform goods into a strategic lever, through qualified negotiation of media spaces and an economic reconciliation system that ensures coherence at every stage - from product allocation to advertising planning to distribution in the pharmacy channel.

Alessandro Tabasso Photo: Courtesy of Milano Finanza

Integrated Trading is based on three key ­elements that define its ­operational ­solidity. 

The first is economic transparency. Each operation is built on shared and traceable parameters: The industry maintains full visibility over the destination of goods and their valuation. In a sector where margin management is central, being able to monitor the entire flow of products introduces a structured level of control capable of overcoming the ambiguities that have historically accompanied traditional barter.

The second is alignment with media planning. The valuation of goods is not disconnected from the communication strategy but is coordinated with media centers and agencies, in line with the timing, spaces, and objectives of the brand, ensuring that advertising planning and distribution proceed in the same direction.

The third is integration with the pharmacy channel, which is increasingly organized into chains and structured networks. In this context, the ability to activate coordinated and systemic networks allows for translating planning into actual shelf presence, strengthening commercial impact.

Today, Value4Pharma operates through a widespread network of over 8,000 pharmacies belonging to strong and light networks. ­According to data from the Osservatorio Catene - Scanner Orizzonti 2025 and New Line Ricerche di Mercato, organized pharmacies represent about 43 percent of total establishments in Italy, a ­significant perimeter where the model finds structured and scalable application, allowing companies to integrate brand awareness and physical presence at the point of sale.

The operational focus primarily concerns Over-the-counter (OTC) and non-­prescription (SOP) products, categories that allow for exposure and communication to the public. However, the goal is not only to create new demand but to assist brands in shifting market shares within existing categories, strengthening shelf presence in line with media planning.

OTC and SOP products are medications intended for the treatment of mild disorders (self-­medication) that can be sold without a medical prescription. The main difference is that OTC products can be displayed to the public and advertised, while SOP products can only be sold with the advice of a pharmacist and cannot be advertised. 

OTC products can be placed on shelves accessible to ­customers and are sold in pharmacies, para-­pharmacies, and large retail corners. Among the most common are pain relievers, cold remedies, and antihistamines. SOP products do not require a prescription, but the pharmacist must recommend their use, so they are not displayed to the public. Advertising is prohibited, and the sale requires interaction with the pharmacist. Both categories are considered safe for self-medication when used correctly, but it is always advisable to consult a pharmacist or doctor to choose the most suitable product.

The solidity of the path is confirmed by the numbers: founded as an Srl (limited liability company), in its second year, ­Value4Pharma counts 32 client industries in the healthcare sector and develops a volume ­approaching 20 million euros of products. In 2025 alone, collaborations were initiated with over 10 companies that had never invested in offline media, ­particularly television, expanding access to communication tools traditionally reserved for more structured players.

In a market where ­margin ­pressure demands greater ­efficiency and control, Integrated Trading emerges as a model capable of uniting entrepreneurial vision, economic rigor, and operational integration. This methodological choice allows companies to free up financial resources, strengthen their presence in the pharmacy channel, and coherently enhance every available lever.

In the Italian healthcare sector, Value4Pharma now positions itself as a unique entity that has industrialized this approach with a specific vertical focus on the pharmacy channel, an evolution that demonstrates how innovation and financial discipline can coexist, transforming a historically tactical practice into a structural lever for growth.

What's pharmaceutical barter?

Pharmaceutical barter is a strategic exchange in which companies in the sector (OTC/SOP drugs, supplements, medical devices) trade their products, often excess inventory, for services of equivalent value, primarily advertising space, marketing campaigns, logistics, or business services. It is a form of modern barter (corporate bartering) that allows for reducing cash costs, optimizing inventory, and increasing visibility.

The key points of pharmaceutical barter are:

Operation: The pharmaceutical company provides its products to a barter company, which in return offers services (eg, media advertising, promotional materials).

Advantages:

Inventory management: Rapid disposal of excess products, supplements, or medical devices, avoiding destruction or storage costs.

Cash savings: Obtaining communication and marketing campaigns without cash outlay.

New channels: Access to alternative and monitored sales or promotion channels.

Tax aspects: From a tax perspective, barter is equated to a swap, with invoice exchanges between the parties in compensation.

Security: The process ensures complete traceability of products, which is essential for the healthcare sector.

This system has proven particularly useful for improving inventory turnover and supporting trade marketing in pharmacies, both for large companies and smaller entities.